There are conflicting data about whether the development of cancer-associated thrombo-embolism (TE) negatively impacts survival in children. The objective was to determine whether TE during treatment was associated with overall survival (OS) and event-free survival (EFS) in children with acute lymphoblastic leukemia (ALL). We performed a population-based retrospective cohort study using the Cancer in Young People-Canada registry. Children <15 years of age diagnosed with de novo ALL (2000-2016). The primary exposure variable was radiologically-confirmed TE requiring medical intervention. Multivariable Cox regression models were used to determine the impact of TE on survival, where TE was time-dependent. We included 2,006 children (median age: 4 years, 88.5% precursor B-cell ALL). TE occurred in 113 patients (5.6%), at a median time of 107 days (interquartile range: 35-184 days) after ALL diagnosis. Among standard/low-risk patients, 41/1165 (3.5%) developed TE while among high/very high-risk patients, 72/841 (8.6%) developed TE. Patients with TE had a significantly worse OS (adjusted HR [aHR] of death: 2.61, 95% CI: 1.62-4.22, p<0.001) and EFS (aHR of an event [death, relapse, second malignancy]: 2.03, 95% CI: 1.35-3.05, p=0.001), compared with patients without TE. No statistically significant difference was seen in standard/low risk ALL for OS and EFS, but TE was associated with a significantly lower OS and EFS in children with high/very high-risk ALL (aHR of death: 2.90, 95% CI: 1.79-4.72, p<0.001; aHR of an event: 2.02, 95% CI: 1.30-3.12, p=0.002). Thus, TE led to a statistically significant reduction in OS and EFS in children with high risk/very high-risk leukemia. This article is protected by copyright. All rights reserved.
Marie-Claude Pelland-Marcotte, Ketan Kulkarni, Uma H Athale, Jason D Pole, Leonardo R Brandão, Lillian Sung